- Filed
- Apr 29, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 24, 2026 | 17.85M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 17.9M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 18.5M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $4.7M |
| Capex | Q1 2026 · Mar 31, 2025 | $9.6M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $5.8M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $11.7M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $195.8M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $197M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.19B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.2B |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $1.27B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $127.3M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $126.1M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $511.4M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $500M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $1.43B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $1.43B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.25 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.25 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.08 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $41.2M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $44.5M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $6.7M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $7.1M |
| Net Income | Q1 2026 · Mar 31, 2026 | $4.5M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.4M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $10.7M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$300K |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $64.6M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $57M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $135.9M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $133.5M |
| Revenue | Q1 2026 · Mar 31, 2026 | $200.5M |
| Revenue | Q1 2026 · Mar 31, 2025 | $190.5M |